Anebulo Pharmaceuticals, Inc.
ANEB
$2.27
-$0.06-2.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 20.39% | -3.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.03% | 23.18% | |||
| Operating Income | 3.03% | -23.18% | |||
| Income Before Tax | -0.63% | -27.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.63% | -27.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.63% | -27.96% | |||
| EBIT | 3.03% | -23.18% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -0.57% | -27.94% | |||
| Normalized Basic EPS | -0.61% | -27.84% | |||
| EPS Diluted | -0.57% | -27.94% | |||
| Normalized Diluted EPS | -0.61% | -27.84% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||